Literature DB >> 32720706

More than just a common cold: Endemic coronaviruses OC43, HKU1, NL63, and 229E associated with severe acute respiratory infection and fatality cases among healthy adults.

Ana B Gorini da Veiga1, Letícia G Martins2, Irina Riediger3, Alix Mazetto3, Maria do Carmo Debur3, Tatiana S Gregianini4.   

Abstract

Respiratory viral infection can cause severe disease and hospitalization, especially among children, the elderly, and patients with comorbidities. In Brazil, the official surveillance system of severe acute respiratory infection (SARI) investigates influenza A (IAV) and B (IBV) viruses, respiratory syncytial virus (RSV), adenovirus (HAdV), and parainfluenza viruses (hPIV 1-3). In Rio Grande do Sul (RS), Brazil, many fatalities associated with SARI between 2013 and 2017 occurred among patients without underlying diseases and for whom the causative agent had not been identified using official protocols. This cross-sectional study analyzed the presence of coronaviruses (HCoV), bocavirus (HBoV), metapneumovirus (hMPV), and rhinovirus in patients who died of SARI despite not having comorbidities, and that were negative for IAV, IBV, RSV, HAdV, and hPIV. Nasopharyngeal aspirates/swabs from patients were used for nucleic acid extraction. The presence of HCoVs OC43, HKU1, NL63, and 229E; HBoV; hMPV; and rhinovirus was assessed by quantitative reverse transcription-polymerase chain reaction. Clinical data were also analyzed. Between 2013 and 2017, 16 225 cases of SARI were reported in RS; 9.8% of the patients died; 20% of all fatal cases were patients without comorbidities and for whom no pathogen was detected using standard protocols. Analysis of 271 of these cases identified HCoV in nine cases; HBoV, hMPV, and rhinovirus were detected in 3, 3, and 10 cases, respectively. Of note, patients infected with HCoV were adults. Results reinforce the importance of including coronaviruses in diagnostic panels used by official surveillance systems because besides their pandemic potential, endemic HCoVs are associated to severe disease in healthy adults.
© 2020 Wiley Periodicals LLC.

Entities:  

Keywords:  coronavirus; epidemiology; infection; respiratory tract

Year:  2020        PMID: 32720706     DOI: 10.1002/jmv.26362

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  10 in total

1.  A Mouse-Adapted Model of HCoV-OC43 and Its Usage to the Evaluation of Antiviral Drugs.

Authors:  Peifang Xie; Yue Fang; Zulqarnain Baloch; Huanhuan Yu; Zeyuan Zhao; Rongqiao Li; Tongtong Zhang; Runfeng Li; Jincun Zhao; Zifeng Yang; Shuwei Dong; Xueshan Xia
Journal:  Front Microbiol       Date:  2022-05-17       Impact factor: 6.064

2.  Individual and Synergistic Anti-Coronavirus Activities of SOCS1/3 Antagonist and Interferon α1 Peptides.

Authors:  Chulbul M Ahmed; Tristan R Grams; David C Bloom; Howard M Johnson; Alfred S Lewin
Journal:  Front Immunol       Date:  2022-06-21       Impact factor: 8.786

3.  Comparison of the clinical characteristics and mortality of adults infected with human coronaviruses 229E and OC43.

Authors:  Won-Il Choi; In Byung Kim; Sang Joon Park; Eun-Hye Ha; Choong Won Lee
Journal:  Sci Rep       Date:  2021-02-24       Impact factor: 4.379

4.  Pan-coronavirus fusion inhibitors as the hope for today and tomorrow.

Authors:  Xinling Wang; Shuai Xia; Yun Zhu; Lu Lu; Shibo Jiang
Journal:  Protein Cell       Date:  2021-01-09       Impact factor: 14.870

5.  First Detection of Human Coronavirus HKU1 in Greece, in an Immunocompromised Patient With Severe Lower Respiratory Tract Infection.

Authors:  Vasiliki Epameinondas Georgakopoulou; Georgios Petsinis; Konstantinos Mantzouranis; Christos Damaskos; Despoina Melemeni; Aikaterini Gkoufa; Serafeim Chlapoutakis; Nikolaos Garmpis; Pagona Sklapani; Nikolaos Trakas; Xanthi Tsiafaki
Journal:  Acta Med Litu       Date:  2021-05-14

6.  Multiscale interactome analysis coupled with off-target drug predictions reveals drug repurposing candidates for human coronavirus disease.

Authors:  Michael G Sugiyama; Haotian Cui; Dar'ya S Redka; Mehran Karimzadeh; Edurne Rujas; Hassaan Maan; Sikander Hayat; Kyle Cheung; Rahul Misra; Joseph B McPhee; Russell D Viirre; Andrew Haller; Roberto J Botelho; Raffi Karshafian; Sarah A Sabatinos; Gregory D Fairn; Seyed Ali Madani Tonekaboni; Andreas Windemuth; Jean-Philippe Julien; Vijay Shahani; Stephen S MacKinnon; Bo Wang; Costin N Antonescu
Journal:  Sci Rep       Date:  2021-12-02       Impact factor: 4.379

7.  Pharmacological inhibition of poly (ADP-ribose) polymerase by olaparib ameliorates influenza-virus-induced pneumonia in mice.

Authors:  Wei Liu; Xiaojuan Ren; Qian Wang; Yan Zhang; Junfeng Du
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2020-08-31       Impact factor: 3.267

8.  Carrageenan nasal spray may double the rate of recovery from coronavirus and influenza virus infections: Re-analysis of randomized trial data.

Authors:  Harri Hemilä; Elizabeth Chalker
Journal:  Pharmacol Res Perspect       Date:  2021-08

9.  Comparative assessment of favipiravir and remdesivir against human coronavirus NL63 in molecular docking and cell culture models.

Authors:  Mirza S Baig; Qiuwei Pan; Yining Wang; Pengfei Li; Sajjan Rajpoot; Uzma Saqib; Peifa Yu; Yunlong Li; Yang Li; Zhongren Ma
Journal:  Sci Rep       Date:  2021-12-06       Impact factor: 4.379

10.  Rhinovirus remains prevalent in school teenagers during fight against COVID-19 pandemic.

Authors:  Di Wu; Jianyun Lu; Zhangyu Sun; Lan Cao; Qing Zeng; Qun Liu; Tiantian Wu; Zhicong Yang
Journal:  Immun Inflamm Dis       Date:  2020-11-28
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.